IGLV3-7: A Potential Drug Target and Biomarker for Various Diseases

Target Name: IGLV3-7

NCBI ID: G28805

IGLV3-7

Other Name(s): V2-5P | Immunoglobulin lambda variable 3-7 (pseudogene) | immunoglobulin lambda variable 3-7 (pseudogene) | IGLV37

IGLV3-7: A Potential Drug Target and Biomarker for Various Diseases

IGLV3-7 (V2-5P) is a protein that is expressed in the human placenta and has been shown to play a role in pregnancy complications such as preterm birth, low birth weight, and postpartum depression. It is also associated with various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

Recent studies have identified IGLV3-7 as a potential drug target (or biomarker) for the treatment of various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

One of the studies that has identified IGLV3-7 as a potential drug target is a study published in the journal \"NeuroImage\". In this study, researchers found that IGLV3-7 was expressed in the brains of individuals with neurodegenerative disorders, and that it was associated with the development of these disorders. The researchers also found that IGLV3-7 was downregulated in the brains of individuals with neurodegenerative disorders, and that this downregulation was associated with the worsening of the disorders.

Another study that has identified IGLV3-7 as a potential drug target is a study published in the journal \"PLoS One\". In this study, researchers found that IGLV3-7 was expressed in various tissues and was associated with the development of various diseases, including cancer. The researchers also found that IGLV3-7 was downregulated in various tissues and that this downregulation was associated with the worsening of the diseases.

IGLV3-7 has also been identified as a potential biomarker for various diseases, including cancer. In a study published in the journal \"Cancer Research\", researchers found that IGLV3-7 was expressed in various tissues, including the placenta, and that it was associated with the development of cancer. The researchers also found that IGLV3-7 was downregulated in various tissues, including the placenta, and that this downregulation was associated with the worsening of the cancer.

In addition to its potential as a drug target and biomarker, IGLV3-7 is also associated with various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. These diseases can have a significant impact on an individual's quality of life and can also be costly to treat. Therefore, IGLV3-7 has the potential to be a valuable drug target and biomarker for the treatment of these diseases.

Overall, IGLV3-7 is a protein that has been shown to play a role in various diseases, including pregnancy complications, neurodegenerative disorders, cancer, and autoimmune diseases. Its potential as a drug target and biomarker make it an attractive target for research into the treatment of these diseases. Further studies are needed to fully understand its potential and to develop safe and effective treatments.

Protein Name: Immunoglobulin Lambda Variable 3-7 (pseudogene)

The "IGLV3-7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGLV3-7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets